11 research outputs found
The role of Preimplantation Factor (PIF) on leukocyte recruitment in vivo
Throughout pregnancy, immune cells infiltrate and colonize the placenta to ensure fetal development and successful birth. Thereby, they regulate tissue remodeling and protect the unborn from invading pathogens. At the same time, immune cells within the placenta require tight regulation in order to prevent recognition of the embryo as a ’semi-allograft’. Extra-embryonic tissue actively modulates immune cell functions by expressing growth factors and cytokines. Preimplanation factor, a 15 amino acid small peptide, is produced by trophoblast cells and continuously secreted into maternal circulation. It has been shown to interfere with immune cell functions in autoimmune disease models, but underlying molecular mechanisms remain unclear.
This work investigated the function of PIF in acute inflammatory scenarios, reflecting its role within maternal serum. Analysis of leukocyte recruitment in postcapillary venules of TNF-α stimulated cremaster muscles in the mouse revealed that (i) leukocyte rolling, (ii) leukocyte adhesion and (iii) neutrophil extravasation is impaired in the presence of PIF. With the help of several ex vivo and in vitro assays, reduced leukocyte rolling could be linked to effects of PIF on the endothelial compartment. Impaired leukocyte adhesion and reduced extravasation in turn could be attributed to a direct effect of PIF on neutrophils. PIF inhibits K+ efflux via the voltage gated potassium channel KV1.3 on neutrophils, thereby reducing sustained calcium influx into the cells. Decreased intracellular Ca2+ concentrations impair post-arrest modification steps, namely neutrophil spreading and adhesion-strengthening, resulting in increased susceptibility to physiological shear forces and in reduced adhesion and extravasation. Taken together, this work demonstrates that PIF modulates neutrophil function during immune responses, offering therapeutic potential beyond pregnancy to protect patients from exuberant inflammation and excess neutrophil recruitment
TRPM7 Kinase Is Essential for Neutrophil Recruitment and Function via Regulation of Akt/mTOR Signaling
During inflammation, neutrophils are one of the first responding cells of innate immunity, contributing to a fast clearance of infection and return to homeostasis. However, excessive neutrophil infiltration accelerates unsolicited disproportionate inflammation for instance in autoimmune diseases such as rheumatoid arthritis. The transient-receptor-potential channel-kinase TRPM7 is an essential regulator of immune system homeostasis. Naive murine T cells with genetic inactivation of the TRPM7 enzyme, due to a point mutation at the active site, are unable to differentiate into pro-inflammatory T cells, whereas regulatory T cells develop normally. Moreover, TRPM7 is vital for lipopolysaccharides (LPS)-induced activation of murine macrophages. Within this study, we show that the channel-kinase TRPM7 is functionally expressed in neutrophils and has an important impact on neutrophil recruitment during inflammation. We find that human neutrophils cannot transmigrate along a CXCL8 chemokine gradient or produce reactive oxygen species in response to gram-negative bacterial lipopolysaccharide LPS, if TRPM7 channel or kinase activity are blocked. Using a recently identified TRPM7 kinase inhibitor, TG100-115, as well as murine neutrophils with genetic ablation of the kinase activity, we confirm the importance of both TRPM7 channel and kinase function in murine neutrophil transmigration and unravel that TRPM7 kinase affects Akt1/mTOR signaling thereby regulating neutrophil transmigration and effector function. Hence, TRPM7 represents an interesting potential target to treat unwanted excessive neutrophil invasion
Extratubular Polymerized Uromodulin Induces Leukocyte Recruitment and Inflammation In Vivo
Uromodulin (UMOD) is produced and secreted by tubular epithelial cells. Secreted UMOD polymerizes (pUMOD) in the tubular lumen, where it regulates salt transport and protects the kidney from bacteria and stone formation. Under various pathological conditions, pUMOD accumulates within the tubular lumen and reaches extratubular sites where it may interact with renal interstitial cells. Here, we investigated the potential of extratubular pUMOD to act as a damage associated molecular pattern (DAMP) molecule thereby creating local inflammation. We found that intrascrotal and intraperitoneal injection of pUMOD induced leukocyte recruitment in vivo and led to TNF-alpha secretion by F4/80 positive macrophages. Additionally, pUMOD directly affected vascular permeability and increased neutrophil extravasation independent of macrophage-released TNF-alpha. Interestingly, pUMOD displayed no chemotactic properties on neutrophils, did not directly activate beta 2 integrins and did not upregulate adhesion molecules on endothelial cells. In obstructed neonatal murine kidneys, we observed extratubular UMOD accumulation in the renal interstitium with tubular atrophy and leukocyte infiltrates. Finally, we found extratubular UMOD deposits associated with peritubular leukocyte infiltration in kidneys from patients with inflammatory kidney diseases. Taken together, we identified extratubular pUMOD as a strong inducer of leukocyte recruitment, underlining its critical role in mounting an inflammatory response in various kidneys pathologies
Prostaglandin E2 receptor 3 signaling is induced in placentas with unexplained recurrent pregnancy losses
Although an inflammatory microenvironment is required for successful implantation, an inflammatory overreaction is one of the causes of unexplained recurrent pregnancy losses (uRPL). Prostaglandin E-2 (PGE(2)) plays a pivotal role in regulating immune balance during early pregnancy, and it can stimulate inflammatory reactions via prostaglandin E-2 receptor 3 (EP3). However, the role of PGE, receptor signaling in the uRPL remains unknown. We aimed to investigate whether EP3 signaling is involved in the mechanism of uRPL. Via immunohistochemistry we could show that the expression of cyclooxygenase-2, EP3 and G protein alpha inhibitor 1 (G(i1)) was enhanced in the decidua of the uRPL group in comparison to the control group in first-trimester placentas. In vitro, we demonstrated that sulprostone (an EP1/EP3 agonist) inhibited the secretion of beta-hCG and progesterone in JEG-3 cells and the secretion of beta-hCG in HTR-8/SVneo cells while it induced the expression of plasminogen activator inhibitor type 1 in JEG-3 cells. In addition, PGE(2)/sulprostone was able to stimulate the expression of G o , phosphorylated-extracellular signal-regulated kinases 1/2 (p-ERK1/2) and p53. L-798,106 (an EP3-specific antagonist) suppressed the expression of EP3 and p-ERK1/2 without affecting the secretion of beta-hCG. Elevated activation of EP3 signaling in first-trimester placentas plays an important role in regulating the inflammatory microenvironment, the hormone secretion of extravillous trophoblasts and the remodeling of extracellular matrix in the fetal-maternal interface. L-798,106 might be a 'potential therapeutic candidate' for the treatment of uRPL
Extracellular MRP8/14 is a regulator of β2 integrin-dependent neutrophil slow rolling and adhesion
Myeloid-related proteins (MRPs) 8 and 14 are cytosolic proteins secreted from myeloid cells as proinflammatory mediators. Currently, the functional role of circulating extracellular MRP8/14 is unclear. Our present study identifies extracellular MRP8/14 as an autocrine player in the leukocyte adhesion cascade. We show that E-selectin-PSGL-1 interaction during neutrophil rolling triggers Mrp8/14 secretion. Released MRP8/14 in turn activates a TLR4-mediated, Rap1-GTPase-dependent pathway of rapid beta 2 integrin activation in neutrophils. This extracellular activation loop reduces leukocyte rolling velocity and stimulates adhesion. Thus, we identify Mrp8/14 and TLR4 as important modulators of the leukocyte recruitment cascade during inflammation in vivo
Extracellular MRP8/14 is a regulator of β2 integrin-dependent neutrophil slow rolling and adhesion
Myeloid-related proteins (MRPs) 8 and 14 are cytosolic proteins secreted from myeloid cells as proinflammatory mediators. Currently, the functional role of circulating extracellular MRP8/14 is unclear. Our present study identifies extracellular MRP8/14 as an autocrine player in the leukocyte adhesion cascade. We show that E-selectin-PSGL-1 interaction during neutrophil rolling triggers Mrp8/14 secretion. Released MRP8/14 in turn activates a TLR4-mediated, Rap1-GTPase-dependent pathway of rapid beta 2 integrin activation in neutrophils. This extracellular activation loop reduces leukocyte rolling velocity and stimulates adhesion. Thus, we identify Mrp8/14 and TLR4 as important modulators of the leukocyte recruitment cascade during inflammation in vivo
The Endothelial Glycocalyx Controls Interactions of Quantum Dots with the Endothelium and Their Translocation across the Blood–Tissue Border
Advances
in the engineering of nanoparticles (NPs), which represent
particles of less than 100 nm in one external dimension, led to an
increasing utilization of nanomaterials for biomedical purposes. A
prerequisite for their use in diagnostic and therapeutic applications,
however, is the targeted delivery to the site of injury. Interactions
between blood-borne NPs and the vascular endothelium represent a critical
step for nanoparticle delivery into diseased tissue. Here, we show
that the endothelial glycocalyx, which constitutes a glycoprotein–polysaccharide
meshwork coating the luminal surface of vessels, effectively controls
interactions of carboxyl-functionalized quantum dots with the microvascular
endothelium. Glycosaminoglycans of the endothelial glycocalyx were
found to physically cover endothelial adhesion and signaling molecules,
thereby preventing endothelial attachment, uptake, and translocation
of these nanoparticles through different layers of the vessel wall.
Conversely, degradation of the endothelial glycocalyx promoted interactions
of these nanoparticles with microvascular endothelial cells under
the pathologic condition of ischemia–reperfusion, thus identifying
the injured endothelial glycocalyx as an essential element of the
blood–tissue border facilitating the targeted delivery of nanomaterials
to diseased tissue
Directional Mast Cell Degranulation of TNF into Blood Vessels Primes Neutrophil Extravasation
Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosis
Onset of cardiovascular complications as a consequence of atherosclerosis exhibits a circadian incidence with a peak in the morning hours. Although development of atherosclerosis extends for long periods of time through arterial leukocyte recruitment, we hypothesized that discrete diurnal invasion of the arterial wall could sustain atherogenic growth. Here, we show that myeloid cell recruitment to atherosclerotic lesions oscillates with a peak during the transition from the activity to the resting phase. This diurnal phenotype is regulated by rhythmic release of myeloid cell-derived CCL2, and blockade of its signaling abolished oscillatory leukocyte adhesion. In contrast, we show that myeloid cell adhesion to microvascular beds peaks during the early activity phase. Consequently, timed pharmacological CCR2 neutralization during the activity phase caused inhibition of atherosclerosis without disturbing microvascular recruitment. These findings demonstrate that chronic inflammation of large vessels feeds on rhythmic myeloid cell recruitment, and lay the foundation for chrono-pharmacology-based therapy